What is MDxHealth SA's share price today?
MDxHealth SA (MDXH) share price today is $0.66 as of October 14, 2026 at 1:30 AM IST. The stock touched a day high of $0.67 and a day low of $0.60.What exchange does MDxHealth SA stock trade on, and under what ticker symbol?
MDxHealth SA stock trades on NASDAQ under the ticker symbol MDXH.What is MDxHealth SA's market capitalization?
MDxHealth SA's market capitalization is $56.26M as of October 14, 2026 at 1:30 AM IST.What is MDxHealth SA's price-to-earnings (P/E) ratio?
MDxHealth SA's price-to-earnings (P/E) ratio is N/A as of October 13, 2026.What is MDxHealth SA's price-to-book (P/B) ratio?
MDxHealth SA's price-to-book (P/B) ratio is 23.63 as of October 13, 2026.Can Indian investors buy MDxHealth SA shares?
Yes, You can buy MDxHealth SA shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in MDxHealth SA shares from India?
Indian investors can buy MDxHealth SA shares in three steps: 1. Search MDxHealth SA on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from MDxHealth SA shares for Indian investors?
Since MDxHealth SA trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in MDxHealth SA shares via Tickertape?
Indian investors can start investing in MDxHealth SA (MDXH) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 15.1285 shares at the current price of $0.66.
$
₹
$0.669.45% (+0.05)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
23.63
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-0.7
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
-32.74%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 6 analysts reports
Buy4 analysts
Hold2 analysts
Sell0 analyst
Price Upside
+172.73%
Earnings Growth
+30.3%
Rev. Growth
-10.9%
Company Profile
Company Profile
ABBV
P/E Ratio
78.09
78.09
1Y Return
22.94%
22.94%
Buy Reco %
80.00
80.00
AMGN
P/E Ratio
25.76
25.76
1Y Return
43.82%
43.82%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
25.13%
25.13%
Buy Reco %
78.57
78.57
P/E Ratio
29.70
29.70
1Y Return
19.11%
19.11%
Buy Reco %
81.25
81.25
MRNA
P/E Ratio
—
—
1Y Return
708.71%
708.71%
Buy Reco %
21.73
21.73
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$0.66Baseline
Analyst Target - 1 year
Target$1.8+172.73%
All values in $
2026
Current$0.66Baseline
Analyst Target - 1 year
Target$1.8+172.73%
All values in $
Revenue Forecast
Revenue Forecast
Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies -10.90% growth, versus a trailing 3-year CAGR of 42.79%.
2025
Current$107.87Baseline
Forecast for Dec 2026
High$97.77-9.36%
Average$96.12-10.9%
Low$94.18-12.69%
All values in $ Million
2025
Current$107.87Baseline
Forecast for Dec 2026
High$97.77-9.36%
Average$96.12-10.9%
Low$94.18-12.69%
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$-0.66Baseline
Forecast for Dec 2026
High$-0.46+30.3%
Average$-0.46+30.3%
Low$-0.46+30.3%
All values in $
2025
Current$-0.66Baseline
Forecast for Dec 2026
High$-0.46+30.3%
Average$-0.46+30.3%
Low$-0.46+30.3%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19.83 | 41.99 | 23.31 | 48.05 | 24.29 | 26.60 | 27.43 | 54.66 | 54.66 | 27.20 |
Gross Profit | 12.06 | 25.34 | 14.27 | 29.79 | 15.50 | 17.56 | 17.87 | 29.30 | 29.30 | 17.88 |
| Net Income | -8.51 | -20.03 | -11.18 | -18.03 | -9.20 | -7.37 | -8.01 | -18.77 | -18.77 | -11.53 |
| Net Profit Margin | -42.91% | -47.71% | -47.98% | -37.51% | -37.90% | -27.70% | -29.19% | -34.34% | -34.34% | -42.38% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareDiagnostics & Research
HealthcareDiagnostics & Research
Valuation
Returns
Forecast
Compare valuation on Screener| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| MDxHealth SA | - | 23.63 | - |
| AbbVie Inc | 78.09 | 50.45 | 0.54 |
| Amgen Inc | 25.76 | 18.78 | 2.45 |
Price Comparison
Price Comparison
Compare MDXH with any stock or ETFCompare MDXH with any stock or ETF
Comparing from
MDXH
ABBV
AMGN
The 12-month consensus target implies 172.73% growth, versus a trailing 3-year CAGR of -38.08%.